Associate Professor Hien Le

Associate Professor Hien Le is an experienced radiation oncologist and clinical researcher consulting at Royal Adelaide Hospital (RAH) and Icon Cancer Centre sites in Windsor Gardens, Adelaide (Kurralta Park) and Noarlunga. He is a passionate advocate for cutting-edge cancer therapies and innovative radiation therapy technology, and dedicated to delivering comprehensive patient-centred care.

In 2003, Hien completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at the University of Adelaide and undertook specialist radiation oncology training and a clinical fellowship at the RAH. In 2011, he became a fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR) and received the RANZCR Windeyer Fellowship award. Completing his Windeyer clinical oncology fellowship at Mount Vernon Cancer Centre (UK), where he gained extensive experience in CyberKnife and MRI-guided brachytherapy techniques. He then subsequently received the RANZCR College Thomas Baker award, travelling to Massachusetts General Hospital (US) to further his knowledge and understanding of proton beam therapy.

Hien enjoys a mixture of clinical work, contributing to leading national and international publications and conferences and attending multidisciplinary meetings. He was the first in SA to treat a patient with stereotactic ablative body radiation therapy. A/Professor Le is the chair of the main neuro-oncology multidisciplinary meeting in SA and a supervisor for Masters and PhD students investigating the management and biology of cancers.

Hien is the Head of Research in the Department of Radiation Oncology at the RAH, Associate Professor at the University of South Australia, and continues to play a key role in the Australian Bragg Centre for Proton Therapy and Research team’s proton-photon comparative planning services.

As an active member of the Trans-Tasman Radiation Oncology Group (TROG) and several leading cancer trial groups, Hien is the lead principal investigator of several open clinical trials. In 2024, he was appointed chair of the TROG Scientific Committee after four years of chairing the TROG Particle Therapy Special Interest Group. Hien has been awarded a number of research grants including the Cooperative Research Centres Projects Grant ($3M in 2023) and Medical Research Future Fund grant for the SOCRATES clinical trial ($2.3M in 2021).

Hien’s clinical experience covers a broad range of solid tumour malignancies, with a special interest in brain and spinal (CNS) cancer, head and neck cancer, liver cancer, lung cancer and pancreatic cancer. He can also speak fluent English and Vietnamese, and takes pride in caring for patients in their preferred language.

A/Prof Hien Le has been a key collaborator in the dissemination of information and international key stakeholder involvement for the Australian Bragg Centre for Proton Therapy and Research.